FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
25 February 2025
25 February 2025
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Apple offers millions of AirPods Pro 2 users with hearing aid features despite turbulence with data assurances amid UK Government demands.
The neurovascular market, estimated at $4.2bn in 2024 by GlobalData, is becoming increasingly specialised and competitive.
The company's submission includes a request to approve the system for all indications currently authorised for its ProSense system.
In partnership with Sekisui Diagnostics, the company and its distribution partners have made the test available across the US.
Cubbie’s multisensory spaces are designed to help neurodivergent individuals manage their conditions.
The ongoing demographic transformation brings both challenges and opportunities, particularly for the medical devices industry.
The innovation has the potential to reshape the pharmaceutical industry’s understanding of disease.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.